-
Treatment of advanced non-small cell lung cancer with driver mutations
27 Mar 2024 01:14 GMT
… directed treatment for patients with advanced stages. The expanding number of drugs … tyrosine kinase inhibitors (EGFR-TKIs), erlotinib, gefitinib, and icotinib; second- … immunotherapy.
Journal
Frontiers of Medicine
Method of Research
Experimental study …
-
Elevated Hepatotoxicity Risk Linked to Cabozantinib in Cancer Treatment
04 Mar 2024 18:56 GMT
… EMBASE databases for randomized controlled trials (RCTs) published from inception … , with patients receiving this treatment exhibiting significantly elevated relative risks … as erlotinib, sunitinib, and sorafenib, as well as non-TKI drugs, including …
-
RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
02 Mar 2024 01:33 GMT
… U.S. Food and Drug Administration (FDA) has approved RYBREVANT® … seeking professional medical advice, diagnosis or treatment by licensed … Information. Horsham, PA: Janssen Biotech, Inc.
The World Health … A phase II trial of adjuvant erlotinib in patients with …
-
Familial Adenomatous Polyposis Market Size is expected to grow by 2032, estimates DelveInsight
26 Mar 2024 06:19 GMT
… Pharma, Cancer Prevention Pharmaceuticals, Janssen Biotech, Cellix Bio, Zikani … trials for REC-4881. This is a Phase 1b/2, trial … Immunotherapy with panitumumab and erlotinib may have a … drug has received Orphan Drug Designation by the FDA for the treatment …
-
The Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial’s Impact
25 Jan 2024 12:33 GMT
… (gefitinib or erlotinib) as first-line treatment for patients with … such as chemotherapy, antibody drug conjugates (ADC), or chemotherapy … in Clinical Trials
In the IMpower 150 trial, 1202 … , Takeda, Janssen, Blueprint Medicine and travel support from AnHeart …
-
Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma
16 Jan 2024 07:17 GMT
… of Maprotiline, an antidepressant medication, as a therapeutic … Drug Administration (FDA) granted approval to Lenvatinib as a first-line treatment … the combination of Erlotinib and Lenvatinib can … pharmaceutical agent under investigation in clinical trials …
-
Treatment with EGFR inhibitors in lung cancer patients tied to increased risk of new-onset keratitis: JAMA
16 Jan 2024 02:10 GMT
… prevent severe complications or treatment disruptions.
"Over … who did not take these drugs (HR 1.520),… with EGFR inhibitors -- including erlotinib (Tarceva), gefitinib (Iressa), … and 2023. Exposures included treatment with epidermal growth factor …
-
Trodelvy interactions: Alcohol, medications, and other factors
05 Jan 2024 16:07 GMT
… erlotinib
Steps you or your doctor may take: Before starting Trodelvy treatment … enough clinical trials to … Drug Administration (FDA). It alerts doctors and patients about drug … doctor or another healthcare professional before taking any medication. The drug …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… drug delivery systems for lung cancer treatment. The trials … 39 while erlotinib inhibits … drug delivery systems for biopharmaceuticals. Pharmaceutics … drug-delivery systems for protein and peptide biopharmaceuticals. Trends in biotechnology. Trends Biotechnol …
-
Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations
13 Nov 2023 09:21 GMT
… significant factor limiting their medical applications.
Nanosuspensions
Nanosuspensions … of erlotinib by solid self nano emulsifying drug delivery … for enhanced breast cancer treatment. Pharmaceutics. 2022;14(11): … . Artif Cells Nanomed Biotechnol. 2018;46(sup1 …